Advanced SearchSearch Tips
Evaluation of a Colorectal Carcinoma Screening Program in Kota Setar and Kuala Muda Districts, Malaysia
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
 Title & Authors
Evaluation of a Colorectal Carcinoma Screening Program in Kota Setar and Kuala Muda Districts, Malaysia
Abu Hassan, Muhammad Radzi; Leong, Tan Wei; Andu, Delarina Frimawati Othman; Hat, Habshoh; Mustapha, Nik Raihan Nik;
  PDF(new window)
Background: A colorectal cancer screening program was piloted in two districts of Kedah in 2013. There is scarcity of information on colorectal cancer screening in Malaysia. Objective: Thus, this research was conducted to evaluate the colorectal cancer screening program in the districts to provide insights intop its efficacy. Materials and Methods: A cross sectional study was conducted using data on the colorectal cancer screening program in 2013 involving Kota Setar and Kuala Muda districts in Malaysia. We determined the response rate of immunochemical fecal occult blood test (iFOBT), colonoscopy compliance, and detection rates of neoplasia and carcinoma. We also compared the response of FOBT by demographic background. Results: The response rate of FOBT for first iFOBT screening was 94.7% while the second iFOBT screening was 90.7%. Participants from Kuala Muda district were 27 times more likely to default while Indians had a 3 times higher risk of default compared to Malays. The colonoscopy compliance was suboptimal among those with positive iFOBT. The most common finding from colonoscopy was hemorrhoids, followed by tubular adenoma. Detection rate of carcinoma and neoplasia for our program was 1.2%. Conclusions: In summary, the response rate of iFOBT was encouraging but the colonoscopy compliance was suboptimal which led to a considerably low detection rate.
Colorectal cancer;screening;iFOBT;colonoscopy;compliance;Kedah;Malaysia;
 Cited by
Cairns SR, Scholefield J (2002). Guidelines for colorectal cancer screening in high risk groups. Gut, 51, 1-2. crossref(new window)

Cairns SR, Scholefield JH, Steele RJ, et al (2010). Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups. Gut, 59, 666-89. crossref(new window)

Castiglione G, Zappa M, Grazzini G, et al (1996). Immunochemical vs guaiac faecal occult blood tests in a population-based screening programme for colorectal cancer. British J Cancer, 74, 141. crossref(new window)

Compton CC, Fielding LP, Burgart LJ, et al (2000). Prognostic factors in colorectal cancer. Arch Pathol Lab Med, 124, 979-94.

Ferrat E, Le Breton J, Veerabudun K, et al (2013). Colorectal cancer screening: factors associated with colonoscopy after a positive faecal occult blood test. Br J Cancer, 109, 1437-44. crossref(new window)

Frazier AL, Colditz GA, Fuchs CS, et al (2000). Costeffectiveness of screening for colorectal cancer in the general population. JAMA, 284, 1954-61. crossref(new window)

Hardcastle JD, Chamberlain JO, Robinson MH, et al (1996). Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet, 348, 1472-7. crossref(new window)

Hewitson P, Glasziou P, Watson E, et al (2008). Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol 103, 1541-9. crossref(new window)

Kronborg O, Fenger C, Olsen J, et al (1996). Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet, 348, 1467-71. crossref(new window)

Launoy GD, Bertrand HJ, Berchi C, et al (2005). Evaluation of an immunochemical fecal occult blood test with automated reading in screening for colorectal cancer in a general average-risk population. Int J Cancer, 115, 493-6. crossref(new window)

Leuraud K, Jezewski-Serra D, Viguier J, et al (2013). Colorectal cancer screening by guaiac faecal occult blood test in France:Evaluation of the programme two years after launching. Cancer Epidemiol, 37, 959-67. crossref(new window)

Logan RF, Patnick J, Nickerson C, et al (2012). Outcomes of the bowel cancer screening programme (BCSP) in England after the first 1 million tests. Gut, 61, 1439-46. crossref(new window)

Meester RG, Doubeni CA, Lansdorp-Vogelaar I, et al (2015). Colorectal cancer deaths attributable to nonuse of screening in the United States. Ann Epidemiol, 25, 208-13. crossref(new window)

Ministry of Health, Malaysia (2007). National cancer registry report: malaysia cancer statistics - data and Figure.

Moss S, Campbell C, Melia J, et al (2011). Performance measures in three rounds of the English bowel cancer screening pilot. Gut, 2010, 236430.

O'Connell JB, Maggard MA, Ko CY (2004). Colon cancer survival rates with the new american joint committee on cancer sixth edition staging. J Natl Cancer Inst, 96, 1420-5. crossref(new window)

Oono Y, Iriguchi Y, Doi Y, et al (2010). A retrospective study of immunochemical fecal occult blood testing for colorectal cancer detection. Clinica Chimica Acta, 411, 802-5. crossref(new window)

Steele R, Kostourou I, McClements P, et al (2010). Effect of gender, age and deprivation on key performance indicators in a FOBT-based colorectal screening programme. J Med Screen, 17, 68-74. crossref(new window)

Winawer S, Fletcher R, Rex D, et al (2003). Colorectal cancer screening and surveillance: clinical guidelines and rationaleupdate based on new evidence. Gastroenterol, 124, 544-60. crossref(new window)